Chad Gassert Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
Chad Gassert has an estimated net worth of at least $25.4 million*, as of Dec. 18, 2024. They own 242,905 shares of ANIP stock. They have sold 200,000 shares of ANIP stock since 2021, for an estimated $11.8 million.
Chad Gassert $ANIP SEC Form 4 Insider Trading
Chad Gassert has filed a total of 12 insider trades in $ANIP since 2021. Their most recent trade was a sale of 20,000 shares, made on Jul 01, 2024. Their largest trade was a sale of 20,000 shares, made on Jul 01, 2024. We estimate that they now own 242,905 shares of $ANIP, worth an estimated $13.6 million.
Insider Trading at $ANIP
There have been a total of 116 insider trades reported at $ANIP since 2021, with 38,796 shares purchased and 1.6 million shares sold. The most active insider traders in $ANIP stock have been Muthusamy Shanmugam, Meredith Cook, and Chad Gassert. The most recent trade was a sale of 7,500 shares reported by STEPHEN P. CAREY (SVP & CFO), made on Dec 17, 2024.
History of Insider Stock Trades by Chad Gassert
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ANIP
|
Sale | 20,000 | Jul 01, 2024 | July 2, 2024, 8:58 p.m. |
|
ANIP
|
Sale | 20,000 | Jun 03, 2024 | June 4, 2024, 6:08 p.m. |
|
ANIP
|
Sale | 20,000 | May 01, 2024 | May 3, 2024, 5:48 p.m. |
|
ANIP
|
Sale | 20,000 | Apr 01, 2024 | April 2, 2024, 6:59 p.m. |
|
ANIP
|
Sale | 20,000 | Mar 11, 2024 | March 13, 2024, 4:44 p.m. |
|
ANIP
|
Sale | 20,000 | Oct 02, 2023 | Oct. 3, 2023, 8 p.m. |
|
ANIP
|
Sale | 20,000 | Sep 01, 2023 | Sept. 5, 2023, 5:06 p.m. |
|
ANIP
|
Sale | 20,000 | Aug 01, 2023 | Aug. 3, 2023, 6:03 p.m. |
|
ANIP
|
Sale | 20,000 | Jul 03, 2023 | July 6, 2023, 4:15 p.m. |
|
ANIP
|
Sale | 20,000 | Jun 22, 2023 | June 23, 2023, 8 p.m. |
|
ANIP
|
Purchase | 5,000 | Mar 18, 2022 | March 22, 2022, 5:37 p.m. |
|
ANIP
|
Purchase | 5,000 | Mar 21, 2022 | March 22, 2022, 5:37 p.m. |
$ANIP Executives and Stock Owners with Insider Trades
-
Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM OPS
-
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC.
-
Chad Gassert, SVP - CORP. DEV. & STRATEGY
-
Nikhil Lalwani, PRESIDENT & CEO
-
Christopher Mutz, HEAD OF RARE DISEASE
-
James G. Marken, SVP OPS & PROD DEV
-
Stephen P. Carey, SVP & CFO
-
Ori Gutwerg, SVP, GENERICS
-
Krista Davis, SVP, CHIEF HR OFFICER
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.